On March 31, 2026, William Blair upgraded 10x Genomics from “Market Perform” to “Outperform,” highlighting its best-in-class genomics platforms and exposure to growing demand for large-scale ...

William Blair upgraded 10x Genomics Inc. TXG stock, citing it as the best-in-class technology and is well-positioned to ...

Andreas Pfenning discusses the techniques being developed and used to study neuronal heterogeneity and the therapeutic potential of his work.

Bioptimus, a global AI company building the world's first world model for biology, today announced the launch of its Spatial ...

Abstract: Spatial transcriptomics (ST) enables the joint profiling of gene expression and spatial localization, offering new insights into tissue microenvironments and biological processes. However, ...

The rapid development of spatial transcriptomics (ST) technologies has greatly advanced the understanding of gene expression, tissue architecture, cellular composition, and disease mechanisms within ...

HONG KONG, Feb. 13, 2026 /PRNewswire/ -- Omics Empower, a global life science service provider specializing in single-cell sequencing and spatial transcriptomics, announced that Xenium™ In Situ ...

HONG KONG, Feb. 13, 2026 /PRNewswire/ — Omics Empower, a global life science service provider specializing in single-cell sequencing and spatial transcriptomics, announced that Xenium™ In Situ Spatial ...

Image source: The Motley Fool. 10x Genomics (NASDAQ:TXG) reported quarterly revenue of $166,000,000, reflecting low single-digit growth and surpassing guidance, while full-year revenue excluding ...

Graph Convolutional Networks (GCNs) are widely applied for spatial domain identification in spatial transcriptomics (ST), where node representations are learned by aggregating information from ...

Initiative will create one of the world's largest multimodal cancer datasets and an integrated suite of AI models and tools to fuel precision medicine PharosAI brings together King's College London, ...